Treatment of Canine Atopic Dermatitis: Updated Guidelines From the International Committee on Allergic Diseases of Animals ( ICADA )
Open Access
- 28 September 2026
- journal article
- review article
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (6) , 963-989
Abstract
Background: Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives: These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous recommendations by organising treatment according to mechanism‐of‐action and by distinguishing two therapeutic phases: reactive therapy to resolve existing pruritus and skin lesions, followed by proactive therapy to maintain remission and reduce flares. Materials and Methods: The literature was reviewed and recommendations are based, where possible, on randomised controlled trials and systematic reviews, with evidence graded using the Strength of Recommendation Taxonomy. The guidelines review skin barrier care, antimicrobial and microbiome‐modulating interventions, avoidance of nonallergenic and allergenic flare factors, allergen‐specific immunotherapy, and anti‐inflammatory, antipruritic and immunomodulatory treatments. Results: Rapid‐acting broad‐spectrum drugs, particularly glucocorticoids, are recommended for reactive treatment. Janus Kinase (JAK) inhibitors and lokivetmab may be effective depending on lesion type, severity and inflammatory complexity. Secondary infections and flare factors must be addressed. Proactive management essential to prevent repeated cycles of inflammation may include skin barrier support, infection control, allergen avoidance, allergen immunotherapy, topical glucocorticoids, ciclosporin, tacrolimus, lokivetmab or JAK inhibitors, selected according to the patient's disease pattern and response. Conclusions and Clinical Relevance: A number of interventions are suitable for the treatment of cAD. Interventions are neither universally required, interchangeable nor effective in all cases. Treatment selection should take into account efficacy, safety, practicality, cost, the quality‐of‐life of both dog and owner, and the legal regulations applicable in the country of use.Keywords
This publication has 185 references indexed in Scilit:
- Minimum inhibitory and bactericidal/fungicidal concentration of commercially available products containing essential oils, zinc gluconate, or 4% chlorhexidine for Malassezia pachydermatis, Pseudomonas aeruginosa, and multi-drug resistant Staphylococcus pseudintermedius canine clinical isolatesVeterinary Research Communications, 2024
- Whole picture of human stratum corneum ceramides, including the chain-length diversity of long-chain basesJournal of Lipid Research, 2022
- Therapies in Canine Atopic DermatitisVeterinary Clinics of North America: Small Animal Practice, 2019
- Adverse food reactions: Pathogenesis, clinical signs, diagnosis and alternatives to elimination dietsThe Veterinary Journal, 2018
- Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitisThe Veterinary Journal, 2016
- Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omegaCytokine, 2014
- The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitisThe Veterinary Journal, 2014
- Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effectsVeterinary Immunology and Immunopathology, 2012
- The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Genes & Nutrition, 2011
- Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapyVeterinary Immunology and Immunopathology, 2008